EcoDrugPlus

Integrin Subunit Alpha 5

Ensembl ID : ENSXMAG00000009571
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSXMAG00000008521
Gene Symbol: ITGAV
3 Cross references
237 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSXMAG00000011009
Gene Symbol: ITGB1
3 Cross references
214 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSXMAG00000026910
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSXMAG00000005318
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSXMAG00000001770
Gene Symbol: ITGB6
3 Cross references
204 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSXMAG00000000593
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSXMAG00000028973
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSXMAG00000026893
Gene Symbol: LOC102217177
3 Cross references
183 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSXMAG00000019862
Gene Symbol: LOC102222149
3 Cross references
207 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSXMAG00000007256
Gene Symbol: IDH1
3 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase [Nadp], Mitochondrial

Ensembl ID : ENSXMAG00000002871
Gene Symbol: LOC102226896
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).